Castle Biosciences (CSTL) Interest Coverage Ratio (2018 - 2026)

Castle Biosciences has disclosed Interest Coverage Ratio across 9 years of filings, most recently posting 137.37 for Q1 2026.

• Interest Coverage Ratio for Q1 2026 came in at 137.37, up 91.64% year-over-year; the trailing twelve-month figure through Mar 2026 was 163.99 (down 589.86% YoY), and the FY2025 annual result was 497.79, down 3412.86% from the prior year.
• Interest Coverage Ratio came in at 137.37 for Q1 2026 at Castle Biosciences, up from 159.46 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 44.02 in Q4 2024 to a low of 8172.0 in Q1 2022.
• The 5-year median for Interest Coverage Ratio is 992.75 (2022), against an average of 2578.68.
• Across the five-year window, Interest Coverage Ratio soared 101.56% in 2024 and sank 1221.94% in 2025, its largest moves.
• Castle Biosciences' Interest Coverage Ratio stood at 5708.0 in 2022, then jumped by 50.44% to 2829.0 in 2023, then jumped by 101.56% to 44.02 in 2024, then sank by 462.23% to 159.46 in 2025, then increased by 13.85% to 137.37 in 2026.
• The last three Interest Coverage Ratio figures came in at 137.37 (Q1 2026), 159.46 (Q4 2025), and 283.5 (Q3 2025), per Business Quant data.